Health Context Therapeutics® Reports Encouraging Preliminary Phase 2 Data for ONA-XR in Metastatic Breast Cancer December 8, 2022
Health AbbVie to Showcase Migraine Portfolio and Pipeline During the 16th European Headache Federation Congress December 6, 2022
Health European Medicines Agency Accepts Tofersen Marketing Authorization Application to Treat Rare, Genetic Form of ALS December 6, 2022
Health Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing December 6, 2022
Health Compugen’s COM701 (anti-PVRIG) in Dual and Triple Combination Demonstrates Preliminary Durable Anti-Tumor Activity and Immune Activation in Patients with Platinum Resistant Ovarian Cancer December 6, 2022